Want to join the conversation?
$ICON cut its 2016 GAAP EPS outlook to $0.75-0.90 from prior forecast of $1.08-1.23 and its non-GAAP EPS outlook to $1.15-1.30 from prior estimate of $1.35-1.50. This will reflect higher expenses associated with new term loan, impact of sale of Badgley Mischka brand, financial restatement adjustments, transition costs and current portfolio trends.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?